Key facts
- It has raised $88.3M across 4 recorded rounds; the latest was Later Stage VC (Series F) ($58.3M) in Dec 2020.
- Sight Sciences has filed 9 Form Ds with the SEC since 2011, most recently Dec 2020 ($23.2M sold to 4 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Sight Sciences
Create free account
No card required
Funding rounds
4 roundsDec 2020Later Stage VC (Series F)$58.3M▮
Mar 2020Later Stage VC (Series E)$30.0M▮
About Sight Sciences
- Industry
- Surgical Devices
PA Mark — not yet priced
Sight Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Sight Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Sight Sciences in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.